The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Alzheimer’s Disease: An Update and Insights Into Pathophysiology
Open accessAbstract
Alzheimer’s disease (AD) is an irreversible brain disorder associated with slow, progressive loss of brain functions mostly in older people. The disease processes start years before the symptoms are manifested at which point most therapies may not be as effective. In the hippocampus, the key proteins involved in the JAK2/STAT3 signaling pathway, such as p-JAK2-Tyr1007 and p-STAT3-Tyr705 were found to be elevated in various models of AD. In addition to neurons, glial cells such as astrocytes also play a crucial role in the progression of AD. Without having a significant effect on tau and amyloid pathologies, the JAK2/STAT3 pathway in reactive astrocytes exhibits a behavioral impact in the experimental models of AD. Cholinergic atrophy in AD has been traced to a trophic failure in the NGF metabolic pathway, which is essential for the survival and maintenance of basal forebrain cholinergic neurons (BFCN). In AD, there is an alteration in the conversion of the proNGF to mature NGF (mNGF), in addition to an increase in degradation of the biologically active mNGF. Thus, the application of exogenous mNGF in experimental studies was shown to improve the recovery of atrophic BFCN. Furthermore, it is now coming to light that the FGF7/FGFR2/PI3K/Akt signaling pathway mediated by microRNA-107 is also involved in AD pathogenesis. Vascular dysfunction has long been associated with cognitive decline and increased risk of AD. Vascular risk factors are associated with higher tau and cerebral beta-amyloid (Aβ) burden, while synergistically acting with Aβ to induce cognitive decline. The apolipoprotein E4 polymorphism is not just one of the vascular risk factors, but also the most prevalent genetic risk factor of AD. More recently, the research focus on AD shifted toward metabolisms of various neurotransmitters, major and minor nutrients, thus giving rise to metabolomics, the most important “omics” tool for the diagnosis and prognosis of neurodegenerative diseases based on an individual’s metabolome. This review will therefore proffer a better understanding of novel signaling pathways associated with neural and glial mechanisms involved in AD, elaborate potential links between vascular dysfunction and AD, and recent developments in “omics”-based biomarkers in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Regev, A., Teichmann, S. A., Lander, E. S., Amit, I., Benoist, C., Birney, E., Bodenmiller, B., Campbell, P., Carninci, P., Clatworthy, M., et al. (2017) · eLife · doi:10.7554/elife.27041 · Cited by 2,232
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
2021 Alzheimer's disease facts and figures
(2021) · Alzheimer's & Dementia · doi:10.1002/alz.12328 · Cited by 2,201
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
Levi-Montalcini, R., & Angeletti, P. U. (1968) · Physiological Reviews · doi:10.1152/physrev.1968.48.3.534 · Cited by 2,016
The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
The JAK/STAT signaling pathway
Rawlings, J. S., Rosler, K. M., & Harrison, D. A. (2004) · Journal of Cell Science · doi:10.1242/jcs.00963 · Cited by 1,858
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651
Regev, A., Teichmann, S. A., Lander, E. S., Amit, I., Benoist, C. O., Birney, E., Bodenmiller, B., & Campbell, P. J. (2017) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-162597 · Cited by 1,399
Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000)
Eng, L. F., Ghirnikar, R. S., & Lee, Y. L. (2000) · Neurochemical Research · doi:10.1023/a:1007677003387 · Cited by 1,369
Personal omics profiling reveals dynamic molecular and medical phenotypes
Chen, R., Mias, G. I., Li-Pook-Than, J., Jiang, L., Lam, H. Y. K., Chen, R., Miriami, E., Karczewski, K. J., Hariharan, M., Dewey, F. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.009 · Cited by 1,291
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280
Synergy between amyloid-β and tau in Alzheimer’s disease
Busche, M. A., & Hyman, B. T. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0687-6 · Cited by 1,242
Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11934 · Cited by 1,202
Signaling through the JAK/STAT pathway, recent advances and future challenges
Kisseleva, T., Bhattacharya, S., Braunstein, J., & Schindler, C. W. (2002) · Gene · doi:10.1016/s0378-1119(02)00398-0 · Cited by 1,154
Cerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102
Sperling, R. A., LaViolette, P. S., O'Keefe, K., O'Brien, J., Rentz, D. M., Pihlajamaki, M., Marshall, G., Hyman, B. T., Selkoe, D. J., Hedden, T., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.003 · Cited by 1,027
Role of oxidative stress in Alzheimer’s disease
HUANG, W.-J., ZHANG, X., & CHEN, W.-W. (2016) · Biomedical Reports · doi:10.3892/br.2016.630 · Cited by 1,023
Disease-associated astrocytes in Alzheimer’s disease and aging
Habib, N., McCabe, C., Medina, S., Varshavsky, M., Kitsberg, D., Dvir-Szternfeld, R., Green, G., Dionne, D., Nguyen, L., Marshall, J. L., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0624-8 · Cited by 1,009
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
FGF/FGFR signaling in health and disease
Xie, Y., Su, N., Yang, J., Tan, Q., Huang, S., Jin, M., Ni, Z., Zhang, B., Zhang, D., Luo, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00222-7 · Cited by 904
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
Bell, R. D., & Zlokovic, B. V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0522-3 · Cited by 860
Alzheimer's disease drug development pipeline: 2019
Cummings, J., Lee, G., Ritter, A., Sabbagh, M., & Zhong, K. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.05.008 · Cited by 762
A Brain-Wide Study of Age-Related Changes in Functional Connectivity
Geerligs, L., Renken, R. J., Saliasi, E., Maurits, N. M., & Lorist, M. M. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhu012 · Cited by 730
The nerve growth factor: thirty-five years later.
Levi-Montalcini, R. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02347.x · Cited by 718
Vascular dysfunction—The disregarded partner of Alzheimer's disease
Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711
Alzheimer's disease drug development pipeline: 2018
Cummings, J., Lee, G., Ritter, A., & Zhong, K. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.03.009 · Cited by 697
Bell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600419 · Cited by 670
Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
Gottesman, R. F., Schneider, A. L. C., Zhou, Y., Coresh, J., Green, E., Gupta, N., Knopman, D. S., Mintz, A., Rahmim, A., Sharrett, A. R., et al. (2017) · JAMA · doi:10.1001/jama.2017.3090 · Cited by 650
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Iivonen, S., Mannermaa, A., Tuomilehto, J., Nissinen, A., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-3-200208060-00006 · Cited by 645
Activation of the JAK-STAT pathway by reactive oxygen species
Simon, A. R., Rai, U., Fanburg, B. L., & Cochran, B. H. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.6.c1640 · Cited by 598
Seiler, M., & Schwab, M. E. (1984) · Brain Research · doi:10.1016/0006-8993(84)91338-6 · Cited by 591
Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides
Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571
Vermunt, L., Sikkes, S. A. M., van den Hout, A., Handels, R., Bos, I., van der Flier, W. M., Kern, S., Ousset, P., Maruff, P., Skoog, I., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.04.001 · Cited by 570
Effects of aging on functional and structural brain connectivity
Damoiseaux, J. S. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.01.077 · Cited by 563
Solomon, A., Kivipelto, M., Wolozin, B., Zhou, J., & Whitmer, R. A. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000231980 · Cited by 557
Alzheimer’s disease drug development pipeline: 2020
Cummings, J., Lee, G., Ritter, A., Sabbagh, M., & Zhong, K. (2020) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12050 · Cited by 557
Alzheimer's disease drug development pipeline: 2017
Cummings, J., Lee, G., Mortsdorf, T., Ritter, A., & Zhong, K. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.05.002 · Cited by 549
Deane, R., Bell, R., Sagare, A., & Zlokovic, B. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787601867 · Cited by 548
Alzheimer’s disease drug development pipeline: 2021
Cummings, J., Lee, G., Zhong, K., Fonseca, J., & Taghva, K. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12179 · Cited by 539
González-Reyes, R. E., Nava-Mesa, M. O., Vargas-Sánchez, K., Ariza-Salamanca, D., & Mora-Muñoz, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00427 · Cited by 527
Metabolic network failures in Alzheimer's disease: A biochemical road map
Toledo, J. B., Arnold, M., Kastenmüller, G., Chang, R., Baillie, R. A., Han, X., Thambisetty, M., Tenenbaum, J. D., Suhre, K., Thompson, J. W., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.020 · Cited by 468
Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging
Soreq, L., Rose, J., Soreq, E., Hardy, J., Trabzuni, D., Cookson, M. R., Smith, C., Ryten, M., Patani, R., & Ule, J. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.011 · Cited by 419
Schwab, M. E., Otten, U., Agid, Y., & Thoenen, H. (1979) · Brain Research · doi:10.1016/0006-8993(79)90303-2 · Cited by 416
Dai, W., Lopez, O. L., Carmichael, O. T., Becker, J. T., Kuller, L. H., & Gach, H. M. (2009) · Radiology · doi:10.1148/radiol.2503080751 · Cited by 398
Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging
Kalpouzos, G., Chételat, G., Baron, J.-C., Landeau, B., Mevel, K., Godeau, C., Barré, L., Constans, J.-M., Viader, F., Eustache, F., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.019 · Cited by 392
Shen, X.-N., Niu, L.-D., Wang, Y.-J., Cao, X.-P., Liu, Q., Tan, L., Zhang, C., & Yu, J.-T. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-319148 · Cited by 388
Astrocyte phenotype in relation to Alzheimer‐type pathology in the ageing brain
Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., Savva, G., Brayne, C., & Wharton, S. B. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.015 · Cited by 381
Elmore, M. R. P., Hohsfield, L. A., Kramár, E. A., Soreq, L., Lee, R. J., Pham, S. T., Najafi, A. R., Spangenberg, E. E., Wood, M. A., West, B. L., et al. (2018) · Aging Cell · doi:10.1111/acel.12832 · Cited by 380
Bruno, M. A., & Cuello, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510645103 · Cited by 344
Kovacs, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020189 · Cited by 321
Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease
Furman, J. L., Sama, D. M., Gant, J. C., Beckett, T. L., Murphy, M. P., Bachstetter, A. D., Van Eldik, L. J., & Norris, C. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2323-12.2012 · Cited by 313
Amyloid Angiopathy–Related Vascular Cognitive Impairment
Greenberg, S. M., Gurol, M. E., Rosand, J., & Smith, E. E. (2004) · Stroke · doi:10.1161/01.str.0000143224.36527.44 · Cited by 298
Stem-cell-derived human microglia transplanted in mouse brain to study human disease
Mancuso, R., Van Den Daele, J., Fattorelli, N., Wolfs, L., Balusu, S., Burton, O., Liston, A., Sierksma, A., Fourne, Y., Poovathingal, S., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0525-x · Cited by 295
Nishitsuji, K., Hosono, T., Nakamura, T., Bu, G., & Michikawa, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.225532 · Cited by 275
Trans-Omics: How To Reconstruct Biochemical Networks Across Multiple ‘Omic’ Layers
Yugi, K., Kubota, H., Hatano, A., & Kuroda, S. (2016) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.12.013 · Cited by 258
Bis, J. C., Jian, X., Kunkle, B. W., Chen, Y., Hamilton-Nelson, K. L., Bush, W. S., Salerno, W. J., Lancour, D., Ma, Y., Renton, A. E., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0112-7 · Cited by 248
Astrocyte dysfunction in Alzheimer disease
Acosta, C., Anderson, H. D., & Anderson, C. M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24075 · Cited by 247
Correct Use of Repeated Measures Analysis of Variance
Park, E., Cho, M., & Ki, C.-S. (2009) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2009.29.1.1 · Cited by 241
Garwood, C. J., Ratcliffe, L. E., Simpson, J. E., Heath, P. R., Ince, P. G., & Wharton, S. B. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12338 · Cited by 233
Rabin, J. S., Schultz, A. P., Hedden, T., Viswanathan, A., Marshall, G. A., Kilpatrick, E., Klein, H., Buckley, R. F., Yang, H.-S., Properzi, M., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1123 · Cited by 221
Zhao, T., Cao, M., Niu, H., Zuo, X., Evans, A., He, Y., Dong, Q., & Shu, N. (2015) · Human Brain Mapping · doi:10.1002/hbm.22877 · Cited by 209
Rocher, A. B., Chapon, F., Blaizot, X., Baron, J.-C., & Chavoix, C. (2003) · NeuroImage · doi:10.1016/j.neuroimage.2003.07.002 · Cited by 204
Melchor, J. P., Pawlak, R., & Strickland, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08867.2003 · Cited by 202
Schuff, N., Matsumoto, S., Kmiecik, J., Studholme, C., Du, A., Ezekiel, F., Miller, B. L., Kramer, J. H., Jagust, W. J., Chui, H. C., et al. (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.04.1233 · Cited by 200
Howard, R., Zubko, O., Bradley, R., Harper, E., Pank, L., O’Brien, J., Fox, C., Tabet, N., Livingston, G., Bentham, P., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.3762 · Cited by 194
New Approaches for the Treatment of Alzheimer’s Disease
Fish, P. V., Steadman, D., Bayle, E. D., & Whiting, P. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.11.034 · Cited by 189
de la Torre, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180004 · Cited by 184
Age, vascular health, and Alzheimer disease biomarkers in an elderly sample
Vemuri, P., Lesnick, T. G., Przybelski, S. A., Knopman, D. S., Lowe, V. J., Graff‐Radford, J., Roberts, R. O., Mielke, M. M., Machulda, M. M., Petersen, R. C., et al. (2017) · Annals of Neurology · doi:10.1002/ana.25071 · Cited by 182
Genomic variants, genes, and pathways of Alzheimer's disease: An overview
Naj, A. C., Schellenberg, G. D., & for the Alzheimer's Disease Genetics Consortium (ADGC) (2017) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32499 · Cited by 179
Pardo, J. V., Lee, J. T., Sheikh, S. A., Surerus-Johnson, C., Shah, H., Munch, K. R., Carlis, J. V., Lewis, S. M., Kuskowski, M. A., & Dysken, M. W. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.12.044 · Cited by 176
AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease
Mizuno, S., Iijima, R., Ogishima, S., Kikuchi, M., Matsuoka, Y., Ghosh, S., Miyamoto, T., Miyashita, A., Kuwano, R., & Tanaka, H. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-52 · Cited by 170
Long noncoding RNAs and Alzheimer's disease
Luo, Q., & Chen, Y. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s107037 · Cited by 162
Kamal, H., Tan, G. C., Ibrahim, S. F., Shaikh, M. F., Mohamed, I. N., Mohamed, R. M. P., Hamid, A. A., Ugusman, A., & Kumar, J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00282 · Cited by 161
Self-citationInnovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF
Mitra, S., Behbahani, H., & Eriksdotter, M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00038 · Cited by 159
The Effectiveness of Vitamin E Treatment in Alzheimer’s Disease
Lloret, A., Esteve, D., Monllor, P., Cervera-Ferri, A., & Lloret, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040879 · Cited by 159
Akinyemi, R., Mukaetova-Ladinska, E., Attems, J., Ihara, M., & Kalaria, R. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990037 · Cited by 152
Langbaum, J. B. S., Chen, K., Launer, L. J., Fleisher, A., Lee, W., Liu, X., Protas, H. D., Reeder, S., Bandy, D. J., Yu, M., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.020 · Cited by 150
Targeting the JAK2/STAT3 axis in Alzheimer's disease
Chiba, T., Yamada, M., & Aiso, S. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903213426 · Cited by 147
Vincent, V. A. M., Tilders, F. J. H., & van Dam, A.-M. (1997) · Glia · doi:10.1002/(sici)1098-1136(199703)19:3<190::aid-glia2>3.0.co;2-3 · Cited by 146
Xekardaki, A., Rodriguez, C. K., Montandon, M., Toma, S., Tombeur, E., Herrmann, F. R., Zekry, D., Lövblad, K., Barkhof, F., Giannakopoulos, P., et al. (2014) · Radiology · doi:10.1148/radiol.14140680 · Cited by 144
Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis
Apostolova, L. G., Risacher, S. L., Duran, T., Stage, E., Goukasian, N., West, J. D., Do, T. M., Grotts, J. F., Wilhalme, H. M., Nho, K. T., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.4198 · Cited by 140
Alexopoulos, P., Sorg, C., Förschler, A., Grimmer, T., Σκώκου, Μ., Wohlschläger, A. M., Perneczky, R., Zimmer, C., Kurz, A., & Preibisch, C. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0226-2 · Cited by 135
Low serum VEGF levels are associated with Alzheimer's disease
Mateo, I., Llorca, J., Infante, J., Rodríguez‐Rodríguez, E., Fernández‐Viadero, C., Peña, N., Berciano, J., & Combarros, O. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00775.x · Cited by 132
Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease
Sharma, V., Kaur, A., & Singh, T. G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110373 · Cited by 130
Candela, P., Gosselet, F., Saint-Pol, J., Sevin, E., Boucau, M.-C., Boulanger, E., Cecchelli, R., & Fenart, L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100462 · Cited by 128
Wegiel, J., Wang, K. C., Tarnawski, M., & Lach, B. (2000) · Acta Neuropathologica · doi:10.1007/s004010000199 · Cited by 124
Alzheimer's disease genetics: current knowledge and future challenges
Hollingworth, P., Harold, D. H., Jones, L., Owen, M. J., & Williams, J. H. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2628 · Cited by 124
Ruganzu, J. B., Zheng, Q., Wu, X., He, Y., Peng, X., Jin, H., Zhou, J., Ma, R., Ji, S., Ma, Y., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113506 · Cited by 124
Age‐Related Changes in Resting‐State Networks of A Large Sample Size of Healthy Elderly
Huang, C., Hsieh, W., Lee, P., Peng, L., Liu, L.-K., Lee, W., Huang, J., Chen, L., & Lin, C. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12396 · Cited by 123
APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease
Reinvang, I., Espeseth, T., & Westlye, L. T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.05.006 · Cited by 119
Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease
Dorey, E., Chang, N., Liu, Q. Y., Yang, Z., & Zhang, W. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1422-z · Cited by 116
Merlini, M., Wanner, D., & Nitsch, R. M. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1560-2 · Cited by 116
Klavins, K., Koal, T., Dallmann, G., Marksteiner, J., Kemmler, G., & Humpel, C. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.05.003 · Cited by 112
Alzheimer's drug‐development pipeline: 2016
Cummings, J., Morstorf, T., & Lee, G. (2016) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.07.001 · Cited by 108
The miRNome of Alzheimer's disease: consistent downregulation of the miR-132/212 cluster
Pichler, S., Gu, W., Hartl, D., Gasparoni, G., Leidinger, P., Keller, A., Meese, E., Mayhaus, M., Hampel, H., & Riemenschneider, M. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.09.019 · Cited by 108
Minocycline in neurodegenerative and psychiatric diseases: An update
Romero‐Miguel, D., Lamanna‐Rama, N., Casquero‐Veiga, M., Gómez‐Rangel, V., Desco, M., & Soto‐Montenegro, M. L. (2020) · European Journal of Neurology · doi:10.1111/ene.14642 · Cited by 102
López González, I., Garcia-Esparcia, P., Llorens, F., & Ferrer, I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020206 · Cited by 101
Zhang, Z., Yu, L., Hui, X.-C., Wu, Z.-Z., Yin, K., Yang, H., & Xu, Y. (2014) · Brain Research · doi:10.1016/j.brainres.2014.03.036 · Cited by 100
Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis.
Jeynes, B., & Provias, J. (2008) · Current Alzheimer Research · doi:10.2174/156720508785908937 · Cited by 99
Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice
Fragkouli, A., Tsilibary, E. C., & Tzinia, A. K. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.06.021 · Cited by 95
He, J., Zhao, X., Xu, L., & Mao, C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190764 · Cited by 94
The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
Schmidt, A. M., Sahagan, B. G., Nelson, R. B., Selmer, J., Rothlein, R., & Bell, J. M. (2009) · PubMed · Cited by 86
Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
Ibrahim, N. H., Yahaya, M. F., Mohamed, W. M. Y., Teoh, S. L., Hui, C. K., & Kumar, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00261 · Cited by 80
Self-citationThe Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease
Samadian, M. M., Gholipour, M., Hajiesmaeili, M., Taheri, M. N., & Ghafouri‐Fard, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.641080 · Cited by 73
Hanzel, C. E., Iulita, M. F., Eyjolfsdottir, H., Hjorth, E., Schultzberg, M., Eriksdotter, M., & Cuello, A. C. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132282 · Cited by 72
Ji, Y., Urakami, K., Adachi, Y., Maeda, M., Isoe, K., & Nakashima, K. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017068 · Cited by 71
Tang, H., Mao, X., Xie, L., Greenberg, D. A., & Jin, K. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.029 · Cited by 69
Pentz, R., Iulita, M. F., Ducatenzeiler, A., Bennett, D. A., & Cuello, A. C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0797-2 · Cited by 68
Kaminari, A., Giannakas, N., Tzinia, A. K., & Tsilibary, E. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-00794-5 · Cited by 65
The effect of apoE on dementia is not through atherosclerosis: The Rotterdam Study
Knittweis, J. W., McMullen, W., Romas, S. N., Mayeux, R. P., Slooter, A. J. C., Ruitenberg, A., van Duijn, C. M., Breteler, M. M. B., & Liu, H. C. (2000) · Neurology · doi:10.1212/wnl.54.12.2356-a · Cited by 62
Wilcock, D. M., Morgan, D., Gordon, M. N., Taylor, T. L., Ridnour, L. A., Wink, D. A., & Colton, C. A. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-115 · Cited by 61
Park, S. Y., Kim, H. Y., Park, H. J., Shin, H. K., Hong, K. W., & Kim, C. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168286 · Cited by 61
The Role of the Blood-Brain Barrier in the Pathogenesis of Senile Plaques in Alzheimer’s Disease
Provias, J., & Jeynes, B. (2014) · International Journal of Alzheimer s Disease · doi:10.1155/2014/191863 · Cited by 60
Changes in Topological Organization of Functional PET Brain Network with Normal Aging
Liu, Z., Ke, L., Liu, H., Huang, W., & Hu, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088690 · Cited by 57
Amyloid-β Interacts with Blood-Brain Barrier Function in Dementia: A Systematic Review
Burgmans, S., van de Haar, H. J., Verhey, F. R. J., & Backes, W. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122155 · Cited by 56
The case for blood–brain barrier dysfunction in the pathogenesis of Alzheimer's disease
Jeynes, B., & Provias, J. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22527 · Cited by 55
Park, K. W., Yoon, H. J., Kang, D., Kim, B. C., Kim, S., & Kim, J. W. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.12.007 · Cited by 54
Activators and inhibitors of the plasminogen system in Alzheimer’s disease
Barker, R. M., Kehoe, P. G., & Love, S. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01394.x · Cited by 52
Tissue plasminogen activator arrests Alzheimer's disease pathogenesis
Oh, S. B., Byun, C. J., Yun, J.-H., Jo, D., Carmeliet, P., Koh, J., & Lee, J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.020 · Cited by 52
Nevado‐Holgado, A. J., Ribé, E. M., Thei, L., Furlong, L. I., Mayer, M. Á., Quan, J., Richardson, J. C., Cavanagh, J., & Lovestone, S. (2019) · Cells · doi:10.3390/cells8050425 · Cited by 52
Oxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability
Uddin, M. S., & Kabir, M. T. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_5 · Cited by 52
Akhter, H., Huang, W.-T., van Groen, T., Kuo, H., Miyata, T., & Liu, R.-M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180241 · Cited by 51
Akhter, H., Katre, A. K., Li, L., Liu, X., & Liu, R.-M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110512 · Cited by 50
Long, Q., Wu, Y.-G., He, L.-L., Ding, L., Tan, A., Shi, H.-Y., & Wang, P. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00425-2 · Cited by 47
Terni, B., & Ferrer, I. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142460 · Cited by 46
Bonte, S., Vandemaele, P., Verleden, S. E., Audenaert, K., Deblaere, K., Goethals, I., & Holen, R. V. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3569-0 · Cited by 46
Memory, thinking, and aging. What we know about what we know.
Teri, L. L., McCurry, S. M., & Logsdon, R. G. (1997) · Europe PMC (PubMed Central) · Cited by 45
Alzheimer’s as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks
Castrillo, J. I., & Oliver, S. G. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2627-5_1 · Cited by 44
Li, W., Liu, H., Yu, M., Zhang, X., Zhang, Y., Liu, H., Wilson, J. X., & Huang, G. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9556-9 · Cited by 43
Yamaji, S., Ishii, K., Sasaki, M., Imamura, T., Kitagaki, H., Sakamoto, S., & Mori, E. (1997) · PubMed · Cited by 42
The effect of APOE on dementia is not through atherosclerosis: The Rotterdam Study
Slooter, A. J. C., Cruts, M., Ott, A., Bots, M. L., Witteman, J. C. M., Hofman, A., Broeckhoven, C. V., Breteler, M. M. B., & van Duijn, C. M. (1999) · Neurology · doi:10.1212/wnl.53.7.1593 · Cited by 41
Chen, W., Wu, L., Hu, Y., Jiang, L., Liang, N., Chen, J., Qin, H., & Tang, N. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01600-0 · Cited by 38
Integrated Approaches for Analyzing U1-70K Cleavage in Alzheimer’s Disease
Bai, B., Chen, P., Hales, C. M., Wu, Z., Pagala, V., High, A. A., Levey, A. I., Lah, J. J., & Peng, J. (2014) · Journal of Proteome Research · doi:10.1021/pr5003593 · Cited by 37
Oxidative Stress and Alzheimer’s Disease
Singh, S. K., Castellani, R. J., & Perry, G. L. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_10 · Cited by 35
Jeynes, B., & Provias, J. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0099-z · Cited by 34
Mechanisms of Neural and Behavioral Dysfunction in Alzheimer’s Disease
Wesson, D. W., Nixon, R. A., Levy, E., & Wilson, D. A. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8177-1 · Cited by 34
Diniz, B. S., Vieira, E. M., Mendes‐Silva, A. P., Bowie, C. R., Butters, M. A., Fischer, C. E., Flint, A., Herrmann, N., Kennedy, J., Lanctôt, K. L., et al. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12129 · Cited by 33
ElAli, A., Bordeleau, M., Thériault, P., Filali, M., Lampron, A., & Rivest, S. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.279 · Cited by 32
Age-Related Regional Network Covariance of Magnetic Resonance Imaging Gray Matter in the Rat
Alexander, G. E., Lin, L., Yoshimaru, E. S., Bharadwaj, P. K., Bergfield, K. L., Hoang, L. T., Chawla, M. K., Chen, K., Moeller, J. R., Barnes, C. A., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00267 · Cited by 32
Pentz, R., Iulita, M. F., Mikutra-Cencora, M., Ducatenzeiler, A., Bennett, D. A., & Cuello, A. C. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105150 · Cited by 31
Corral‐Jara, K. F., Nuthikattu, S., Rutledge, J. C., Villablanca, A. C., Morand, C., Schroeter, H., & Milenković, D. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.622640 · Cited by 29
Nuzzo, D., Inguglia, L., Walters, J., Picone, P., & Carlo, M. D. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00925 · Cited by 26
Staging Alzheimer’s Disease in the Brain and Retina of B6.APP/PS1 Mice by Transcriptional Profiling
Chintapaludi, S. R., Uyar, A., Jackson, H. M., Acklin, C. J., Wang, X., Sasner, M., Carter, G. W., & Howell, G. R. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190793 · Cited by 26
Synergistic Effect of Amyloid-β and Tau Disrupts Neural Circuits
Tripathi, T., & Kalita, P. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00037 · Cited by 24
Takahashi, W., Takagi, S., Ide, M., Shohtsu, A., & Shinohara, Y. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00286-0 · Cited by 21
Personalized Medicine for Effective Alzheimer Disease Treatment
Kosik, K. S. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.3445 · Cited by 20
Prom-in, S., Kaewsrichan, J., Wangpradit, N., Hui, C. K., Yahaya, M. F., Kamisah, Y., & Kumar, J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17155513 · Cited by 20
Self-citationNuthikattu, S., Milenković, D., Norman, J., Rutledge, J. C., & Villablanca, A. C. (2021) · Nutrients · doi:10.3390/nu13113913 · Cited by 20
The Emerging Role of Metalloproteomics in Alzheimer’s Disease Research
Hare, D. J., Rembach, A., & Roberts, B. R. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_22 · Cited by 17
Olive and Its Phenolic Compound as the Promising Neuroprotective Agent
Kamil, K., Kumar, J., Yazid, M. D., & Idrus, R. B. H. (2018) · Sains Malaysiana · doi:10.17576/jsm-2018-4711-24 · Cited by 17
Self-citationPlasma Proteomics Biomarkers in Alzheimer’s Disease: Latest Advances and Challenges
Perneczky, R., & Guo, L. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_32 · Cited by 12
Use of “omics” technologies to dissect neurologic disease
Tosto, G., & Reitz, C. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802973-2.00006-9 · Cited by 8
Nuthikattu, S., Milenković, D., Rutledge, J. C., & Villablanca, A. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218146 · Cited by 8
Chen, B. J., Mills, J. D., Janitz, C., & Janitz, M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_20 · Cited by 6
Kamal, H., Kamil, K., Tan, K. W. N., Amiruddin, A. L. N. B., Singh, M. K. P., Johaniff, N. A. B., Halim, N. B. A., Nawi, A. M., Chua, K. H., & Kumar, J. K. J. (2021) · Sains Malaysiana · doi:10.17576/jsm-2021-5012-06 · Cited by 5
Self-citation
Cited by
Cary, G. A., Wiley, J. C., Gockley, J., Keegan, S., Amirtha Ganesh, S. S., Heath, L., Butler, R. R., Mangravite, L. M., Logsdon, B. A., Longo, F. M., et al. (2024) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12461 · Cited by 49
AdipoRon’s Impact on Alzheimer’s Disease—A Systematic Review and Meta-Analysis
Barbalho, S. M., Laurindo, L. F., de Oliveira Zanuso, B., da Silva, R. M. S., Gallerani Caglioni, L., Nunes Junqueira de Moraes, V. B. F., Fornari Laurindo, L., Dogani Rodrigues, V., da Silva Camarinha Oliveira, J., Beluce, M. E., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020484 · Cited by 18
Navarro-Gómez, N., Valdes-Gonzalez, M., Garrido-Suárez, B. B., & Garrido, G. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.2 · Cited by 7
“More recently, some emerging neural and glial signaling pathways, including the nerve growth factor (NGF) metabolic pathway, janus kinase/signal transducer and activator of the transcription (JAK2/ STAT3) pathways in reactive astrocytes, and vascular dysfunction, have been implicated in the progression of this complex…”
Background
Metadata
- Authors
- Abubakar, M. B., Sanusi, K. O., Ugusman, A., Mohamed, W., Kamal, H., Ibrahim, N. H., Khoo, C. S., & Kumar, J.
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2022-03-30
- Volume
- 14
- Pages
- 742408-742408
- ISSN
- 1663-4365 (ISSN-L)
- OpenAlex
- W4221128145
- Cited by
- 279
- References
- 159
- FWCI
- 27.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.